- 5 resultados
menor preço: € 76.99, preço mais alto: € 200.35, preço médio: € 156.62
1
Cancer Immunology and Immunotherapy | Glenn Dranoff | Buch | Current Topics in Microbiology and Immunology | HC runder Rücken kaschiert | XIV | Englisch | 2011 | Springer-Verlag GmbH - Dranoff, Glenn
Encomendar
no/na booklooker.de
€ 182.50
Envio: € 0.001
EncomendarLink patrocinado
Dranoff, Glenn:

Cancer Immunology and Immunotherapy | Glenn Dranoff | Buch | Current Topics in Microbiology and Immunology | HC runder Rücken kaschiert | XIV | Englisch | 2011 | Springer-Verlag GmbH - encadernada, livro de bolso

2011, ISBN: 9783642141355

[ED: Gebunden], [PU: Springer-Verlag GmbH], The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal impo… mais…

Custos de envio:Versandkostenfrei, Versand nach Deutschland. (EUR 0.00) preigu
2
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344)
Encomendar
no/na Amazon.de (Intern. Bücher)
€ 198.80
Envio: € 3.001
EncomendarLink patrocinado
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344) - encadernada, livro de bolso

2011, ISBN: 9783642141355

Springer, Gebundene Ausgabe, Auflage: 2011, 320 Seiten, Publiziert: 2011-04-15T00:00:01Z, Produktgruppe: Buch, 1.43 kg, Immunsystem, Körperteile, Medizin, Kategorien, Bücher, Onkologie & … mais…

Custos de envio:Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 3.00)
3
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344)
Encomendar
no/na Amazon.de (Intern. Bücher)
€ 200.35
Envio: € 3.001
EncomendarLink patrocinado
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344) - encadernada, livro de bolso

2011

ISBN: 9783642141355

Springer, Gebundene Ausgabe, Auflage: 2011, 320 Seiten, Publiziert: 2011-04-15T00:00:01Z, Produktgruppe: Buch, 1.43 kg, Immunsystem, Körperteile, Medizin, Kategorien, Bücher, Onkologie & … mais…

Custos de envio:Gewöhnlich versandfertig in 2 bis 3 Tagen. Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 3.00) buchbaer
4
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344)
Encomendar
no/na Amazon.de (Intern. Bücher)
€ 76.99
Envio: € 3.001
EncomendarLink patrocinado
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344) - encadernada, livro de bolso

2011, ISBN: 9783642141355

Springer, Gebundene Ausgabe, Auflage: 2011, 320 Seiten, Publiziert: 2011-04-15T00:00:01Z, Produktgruppe: Buch, 1.43 kg, Immunsystem, Körperteile, Medizin, Kategorien, Bücher, Onkologie & … mais…

Custos de envio:Gewöhnlich versandfertig in 6 bis 7 Tagen. Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 3.00) Paper Cavalier Deutschland
5
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344) - Dranoff, Glenn
Encomendar
no/na AbeBooks.de
€ 124.45
Envio: € 30.901
EncomendarLink patrocinado
Dranoff, Glenn:
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344) - encadernada, livro de bolso

2011, ISBN: 3642141358

[EAN: 9783642141355], Gebraucht, sehr guter Zustand, [PU: Springer], In Used Condition, Books

NOT NEW BOOK. Custos de envio: EUR 30.90 Byrd Books, Austin, TX, U.S.A. [83414208] [Rating: 5 (von 5)]

1Como algumas plataformas não transmitem condições de envio e estas podem depender do país de entrega, do preço de compra, do peso e tamanho do item, de uma possível adesão à plataforma, de uma entrega direta pela plataforma ou através de um fornecedor terceirizado (Marketplace), etc., é possível que os custos de envio indicados pela terralivro não correspondam aos da plataforma ofertante.

Dados bibliográficos do melhor livro correspondente

Pormenores referentes ao livro
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344)

The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment.

Dados detalhados do livro - Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344)


EAN (ISBN-13): 9783642141355
ISBN (ISBN-10): 3642141358
Livro de capa dura
Ano de publicação: 2011
Editor/Editora: Dranoff, Glenn, Springer
304 Páginas
Peso: 0,605 kg
Língua: eng/Englisch

Livro na base de dados desde 2007-11-22T19:26:21-02:00 (Sao Paulo)
Página de detalhes modificada pela última vez em 2024-01-10T14:45:12-03:00 (Sao Paulo)
Número ISBN/EAN: 3642141358

Número ISBN - Ortografia alternativa:
3-642-14135-8, 978-3-642-14135-5
Ortografia alternativa e termos de pesquisa relacionados:
Autor do livro: dran
Título do livro: the topic cancer, cancer immunology immunotherapy, current topics microbiology and immunology, 344


Dados da editora

Autor: Glenn Dranoff
Título: Current Topics in Microbiology and Immunology; Cancer Immunology and Immunotherapy
Editora: Springer; Springer Berlin
306 Páginas
Ano de publicação: 2011-04-15
Berlin; Heidelberg; DE
Impresso / Feito em
Língua: Inglês
213,99 € (DE)
219,99 € (AT)
236,00 CHF (CH)
POD
XIV, 306 p.

BB; Hardcover, Softcover / Medizin/Nichtklinische Fächer; Onkologie; Verstehen; Medizin, Gesundheit; dendritic cells; immune infiltration; regulatory T cells; signal transducer and activator of transcription 3 (Stat3); tumor-immune interactions; Cancer Biology; Immunology; Immunologie; BC

The recent FDA approval of Provenge® as the first therapeutic cancer vaccine together with the recent demonstration that Ipilimumab®, a monoclonal antibody that blocks the negative immune checkpoint cytotoxic T lymphocyte associated antigen-4, prolongs patient survival are major achievements that usher in a new era of cancer immunotherapy. These “first-in-class” treatments reflect the substantive progress that basic and translational scientists have made towards understanding the mechanisms underlying protective tumor immunity in cancer patients Immunotherapies were first explored at the turn of the twentieth century, but the crafting of potent treatments required more detailed knowledge of how the immune system responds to cancer. Advances in genetic, cellular, and biochemical technologies have begun to yield this critical information, focusing attention on immune recognition, regulation, and escape. Indeed, the dynamic interplay of these processes in the tumor microenvironment is now recognized to play a decisive role in determining disease outcome. This volume highlights the rapid progress and breadth of research in cancer immunology, and provides a framework for anticipating many more clinical successes in cancer immunotherapy.
The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Includes supplementary material: sn.pub/extras

< Para arquivar...